BlackRock’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,182,942
| Closed | -$31.9M | – | 5780 |
|
|
2022
Q4 | $31.9M | Sell |
1,182,942
-3,588
| -0.3% | -$94.4K | ﹤0.01% | 2771 |
|
|
2022
Q3 | $21.3M | Buy |
1,186,530
+85,192
| +8% | +$1.36M | ﹤0.01% | 2997 |
|
|
2022
Q2 | $13.7M | Sell |
1,101,338
-101,637
| -8% | -$1.12M | ﹤0.01% | 3322 |
|
|
2022
Q1 | $16M | Buy |
1,202,975
+41,087
| +4% | +$551K | ﹤0.01% | 3310 |
|
|
2021
Q4 | $18.1M | Buy |
1,161,888
+26,253
| +2% | +$501K | ﹤0.01% | 3332 |
|
|
2021
Q3 | $25.5M | Buy |
1,135,635
+77,322
| +7% | +$1.7M | ﹤0.01% | 3124 |
|
|
2021
Q2 | $24.1M | Buy |
1,058,313
+102,961
| +11% | +$2.17M | ﹤0.01% | 3189 |
|
|
2021
Q1 | $19.7M | Buy |
955,352
+775,758
| +432% | +$17.7M | ﹤0.01% | 3194 |
|
|
2020
Q4 | $4.96M | Sell |
179,594
-4,555
| -2% | -$88.7K | ﹤0.01% | 3712 |
|
|
2020
Q3 | $2.59M | Buy |
184,149
+9,824
| +6% | +$183K | ﹤0.01% | 3831 |
|
|
2020
Q2 | $3.6M | Buy |
174,325
+116,697
| +203% | +$1.59M | ﹤0.01% | 3647 |
|
|
2020
Q1 | $436K | Buy |
57,628
+6,694
| +13% | +$75.1K | ﹤0.01% | 4083 |
|
|
2019
Q4 | $791K | Sell |
50,934
-8,266
| -14% | -$83.3K | ﹤0.01% | 4064 |
|
|
2019
Q3 | $308K | Buy |
59,200
+14,563
| +33% | +$108K | ﹤0.01% | 4256 |
|
|
2019
Q2 | $404K | Buy |
44,637
+16,580
| +59% | +$247K | ﹤0.01% | 4233 |
|
|
2019
Q1 | $670K | Buy |
28,057
+145
| +0.5% | +$2.97K | ﹤0.01% | 4034 |
|
|
2018
Q4 | $458K | Buy |
27,912
+1,386
| +5% | +$27.3K | ﹤0.01% | 4080 |
|
|
2018
Q3 | $705K | Sell |
26,526
-521,074
| -95% | -$11.8M | ﹤0.01% | 4051 |
|
|
2018
Q2 | $12.5M | Sell |
547,600
-444,378
| -45% | -$9.7M | ﹤0.01% | 3122 |
|
|
2018
Q1 | $21.1M | Sell |
991,978
-24,943
| -2% | -$380K | ﹤0.01% | 2741 |
|
|
2017
Q4 | $12.9M | Buy |
1,016,921
+872
| +0.1% | +$11.7K | ﹤0.01% | 3021 |
|
|
2017
Q3 | $15.7M | Buy |
1,016,049
+18,464
| +2% | +$225K | ﹤0.01% | 2922 |
|
|
2017
Q2 | $11.7M | Sell |
997,585
-367,561
| -27% | -$4.55M | ﹤0.01% | 3079 |
|
|
2017
Q1 | $16M | Buy |
1,365,146
+1,275,997
| +1,431% | +$14.6M | ﹤0.01% | 2877 |
|
|
2016
Q4 | $1.11M | Buy |
+89,149
| New | +$1.03M | ﹤0.01% | 1459 |
|
Other funds holding MYOV
BlackRock's MYOV Position: Q1 2023 in Review
BlackRock sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 1,182,942 shares — an estimated $31.9M sold.
BlackRock first reported a position in MYOV in Q4 2016 and held it in 25 quarters. The position peaked at $31.9M in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.
- BlackRock reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
- BlackRock sold 1,182,942 Myovant Sciences Ltd. shares in Q1 2023, an estimated $31.9M.
- BlackRock first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 25 quarters.
- BlackRock's Myovant Sciences Ltd. position peaked at $31.9M in Q4 2022.
- 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.
Based on BlackRock's 13F filing for Q1 2023, filed 12 May 2023.